Cannabidiol Market Insights
The Cannabidiol market is projected to be worth USD 19.40 Billion by 2030, registering a CAGR of 15.9% CAGR during the forecast period (2022-2030), the market was valued at USD 5.14 Billion in 2021. In 2021, the marijuana market category dominated with a revenue share of more than 51.2% owing to the rising acceptability of refined CBD products as well as the rising legalization of marijuana. In 2021, the Business to Business (B2B) market segment dominated with a revenue share of more than 49.7% due to the rising number of bulk selling CBD oil. In the regional segment, North America led the Cannabidiol market in 2021 with a revenue share of over 83.8% and is anticipated lead during the forecast period.
Cannabidiol Market Dynamics:
The second most common active component in cannabis is CBD, or Cannabidiol also called marijuana. While CBD is a crucial component of medicinal marijuana, it is either produced in a lab or is taken directly from the hemp plant, a relative of the marijuana plant. Further, due to its absence of psychotropic effects, Cannabidiol is most frequently employed for medicinal purposes. Cannabidiol oil is utilized in numerous medical procedures, including the treatment of anxiety and depression, stress reduction, diabetes prevention, pain relief, cancer symptom relief, and inflammation.
Driver:
Increasing government approvals, rising acceptance, and the use of products are the major factors driving the growth of the market. Further, the healing properties of cannabidiol and the increasing demand for CBD for health and wellness are expected to boost the growth of the market.
Restraint:
Strict regulations and the expensive price of Cannabidiol products are two of the main obstacles preventing the market from expanding. Another significant issue hindering market expansion is the absence of legalization measures in several Asian and African nations.
COVID-19 Analysis of Cannabidiol Market:
Unprecedented lockdowns brought on by the COVID-19 epidemic have disrupted daily life and altered consumer behavior in almost every sector. Retail establishments have closed while COVID-19 reaction efforts intensify. Due to the statewide suspension of transportation and manufacture in significant raw material-producing nations like China and India, the industry began to experience a supply deficit. Additionally, the availability of additional raw materials has been restricted as a result of supply chain disruptions in the U.S., which is impacting manufacturing and, consequently, the supply chain of CBD consumer health products.
Cannabidiol Market Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 19.40 Billion |
| CAGR (2022-2030) | 15.9% |
| By Source Type | · Hemp
· Marijuana |
| By Sales Type | · B2B
o By End-use § Pharmaceuticals § Wellness · B2C o By Sales Channel § Hospital Pharmacies § Online § Retail Stores o By End-use § Medical § Personal Use |
| By End Use | · Medical
· Personal Use · Pharmaceuticals · Wellness |
| By geography | North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) The Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA) |
| Key Players | ENDOCA; Cannoid, LLC; Medical Marijuana, Inc.; Folium Biosciences; Elixinol; NuLeaf Naturals, LLC; Isodiol International, Inc.; Pharmahemp d.o.o. |
Cannabidiol Market Segment Analysis:
By Source Type
In 2021, the marijuana market category dominated with a revenue share of more than 51.2%. The segment is being driven by the rising acceptability of refined CBD products as well as the rising legalization of marijuana and goods derived from it for a variety of medical uses. The high efficacy of Cannabidiol derived from marijuana is another important reason driving the segment’s rise. Further, increasing demand from the pharmaceutical industry and growing consumer awareness of health issues are expected to lead to a significant increase in the market for cannabidiol derived from hemp. The demand for cannabidiol in the pharmaceutical industry is predicted to increase as consumer disposable income rises and medical marijuana is legalized. Some of the CBD products that are in high demand include oils, tinctures, concentrates, capsules, topical treatments such as creams, lip balms, lotions, and consumables like baked goods, coffee, chocolates, gum, and sweets.
By Sales Type
In 2021, the Business to Business (B2B) market segment dominated with a revenue share of more than 49.7%. Over the forecast period, the market is anticipated to grow profitably. This is due to a rise in the number of firms selling CBD oil in bulk or at wholesale prices as well as a rise in the demand for CBD oil as a raw material. Similar to this, more consumers gained interest in purchasing CBD products after legalization in several nations, which provided profitable opportunities to the Cannabidiol market.
By End Use
The pharmaceuticals segment is dominating the market in terms of B2B end use in 2021, accounting for a revenue share of over 67.9.0%. Over the forecast period, the market is expected to expand profitably. In the forthcoming years, product demand is expected to be driven by the increasing number of ongoing studies looking at how CBD affects specific health concerns. various companies also produce products with CBD infusions and purchase CBD oils in large quantities. These products are used by a sizable customer base as a pain and stress treatment solution. Due to this, it can be seen that the bulk of these products is in the market’s growth phase. The pharmaceutical segment is expected to be the fastest growing segment in the Cannabidiol market. Further, growing awareness in terms of the medical benefits of Cannabidiol, including its healing properties is anticipated to fuel the growth of the Cannabidiol market.
By Region
In the regional segment, North America led the Cannabidiol market in 2021 with a revenue share of over 83.8% and is anticipated lead during the forecast period. Some of the key factors influencing the regional market are the presence of a significant population with a high focus on health, the growing acceptance of CBD-based products, the presence of substantial manufacturers, and the ratification of the Farm Bill in the U.S. in 2021. The most forward-thinking location for cannabis and its byproducts, such as Cannabidiol, is North America. In relation to the use of CBD products, it has the most CBD firms and lax laws.
Cannabidiol Market Competitive Landscape:
The competitive landscape of the market has been analyzed in the report, along with the detailed profiles of the major players operating in the industry. Further, the surge in Research and Development (R&D), Product & Service innovation, various business strategies, and Product & Service launches have accelerated the growth of the Cannabidiol market. Key players in the market include-
- ENDOCA
- Cannoid, LLC
- Medical Marijuana, Inc.
- Folium Biosciences
- Elixinol
- NuLeaf Naturals, LLC
- Isodiol International, Inc.
- Pharmahemp d.o.o.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Source Type Picture of Cannabidiol
- Global Cannabidiol Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Cannabidiol Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Therapeutic
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Source Type Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Cannabidiol Market demand
- Post-Covid Impact on Cannabidiol Market Demand
- Impact Analysis of Russia-Ukraine Conflict
- Drivers
- Global Cannabidiol Market Segmentation, Revenue (USD Billion), (2022-2030)
- By Source Type
- Hemp
- Marijuana
- By Sales Type
- B2B
- By End-use
- Pharmaceuticals
- Wellness
- B2C
- By Sales Channel
- Hospital Pharmacies
- Online
- Retail Stores
- By End-use
- Medical
- Personal Use
- By End Use
- Medical
- Personal Use
- Pharmaceuticals
- Wellness
- By Sales Channel
- By End-use
- B2B
- By Source Type
- Global Cannabidiol Market Overview, By Region
- North America Cannabidiol Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Source Type
- By Sales Type
- By End Use
- Canada
- Mexico
- US
- Europe Cannabidiol Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Cannabidiol Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Cannabidiol Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Cannabidiol Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Cannabidiol Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Cannabidiol Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Siemens Healthineers
- Business Overview
- Business Financials (USD Billion)
- Source Type Category, Source, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- ENDOCA
- Cannoid, LLC
- Medical Marijuana, Inc.
- Folium Biosciences
- Elixinol
- NuLeaf Naturals, LLC
- Isodiol International, Inc.
- Pharmahemp d.o.o.
- Siemens Healthineers
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.